You are using an older browser version. Please use a supported version for the best MSN experience.

Fmr. FDA Commissioner Scott Gottlieb on Remdesivir data that shows improved Covid-19 recovery

Former FDA Commissioner Scott Gottlieb joins “Closing Bell” to talk about Gilead’s coronavirus treatment that has been shown to reduce the risk of death in sick patients by 62 percent compared with standard care. Gilead, the company that produces this drug, said its findings must be further investigated in future trials.
image beaconimage beaconimage beacon